CLSA Board of Directors
Global Head, Johnson & Johnson Innovation, JLABS
William J. Newell
Chief Executive Officer, Sutro Biopharma, Inc.
Corporate Vice President, Public Affairs, Edwards Lifesciences
Partner, Hogan Lovells US LLP
Partner, Covington & Burling LLP
Chief Executive Officer OncoCyte
David Beier, J.D.
Managing Director, Bay City Capital
Victoria H. Blatter
Senior Vice President, U.S. Government Affairs, Amgen
Senior Vice President, Government Affairs and Policy, Gilead Sciences
Senior Vice President, Access & External Affairs, Genentech
National Vice President, State Government Relations, Pfizer
David H. Crean
Managing Partner, Cardiff Advisory, LLC
Vice President of Public Policy and Government Affairs, Biogen
Kyle W. Gano, Ph.D.
Chief Business Development and Strategy Officer, Neurocrine Biosciences, Inc.
Julie Gilmore, Ph.D.
Site Head and Chief Operating Officer, Lilly Gateway Labs
Principal, Healthcare and Life Sciences, KPMG
Chief Financial Officer, Gossamer Bio
Elizabeth Grammer, Esq.
Executive Vice President, General Counsel and Head of Human Resources, Ardelyx, Inc.
CEO, Co-Founder and Board Chair of Candesant Biomedical
Jennifer A. Johnson, Ph.D.
Associate General Counsel, DuPont Nutrition & Biosciences
President and CEO, Ambys Medicines
Andrew G. Kaplan
VP, U.S. Public Affairs, Takeda Pharmaceuticals USA, Inc.
Steve A. Kay, Ph.D., D.Sc.
Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California
CEO, Co-founder, and Chairman, Cortexyme
Principal, Life Science Practice, Deloitte
Chief Financial and Business Officer of Nkarta Therapeutics
President and Chief Executive Officer, CytomX
Grace Han McMahon
Head of Transactions, Pacific Innovation Hub, Business Development & Licensing, Merck Research Laboratories
Shlomo Melmed, MB, ChB, MACP
Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System
Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP
General Counsel & Corporate Secretary at Revance Therapeutics, Inc
Senior Vice President, Managed Markets and Government Affairs, GlaxoSmithKline
Founder, CEO, and Chairman, Viscient Biosciences
President and Chief Executive Officer, Codexis
Christian W. Nolet
Joshua J. Ofman, M.D., M.S.H.S
Chief of Corporate Strategy and External Affairs, Grail
Christoph Pittius, Ph.D.
Senior Vice President, Research Business Development, City of Hope
Vice President and General Manager, Neurovascular, Medtronic
Ganesh Raman, Ph.D.
Associate Vice Chancellor for Research, California State University
Chetana Rao, Ph.D.
Head, Site Strategy & Operations, Bristol-Myers Squibb, Redwood City
Co-Chief Executive Officer, Alexandria Real Estate (ARE)
Wendye Robbins, MD
President & CEO, Blade Therapeutics
Daria Mochly-Rosen, Ph.D.
The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine
Terry Rosen, Ph.D.
Chief Executive Officer, Arcus Biosciences
Senior Vice President, Strategy & Corporate Affairs, Nektar Therapeutics
George Savage M.D.
Chief Creative Officer, W20 Group
Lesley Stolz, Ph.D.
Managing Director, Lasana Partners
Elizabeth Thompson, Ph.D.
Group Vice President, Development and External Search, Horizon Therapeutics
Founder and President, Toft Group Executive Search, a ZRG Company
Mohit Trikha, Ph.D.
Vice President, Head of Oncology Early Development, AbbVie
Harold E. Van Wart, Ph.D.
Vice-President, Government Affairs and Public Policy, Boehringer Ingelheim
Senior Vice President, Diabetes Care, Abbott
Rick E Winningham
Chairman and CEO, Theravance Biopharma
CEO & Founder, Verge Genomics